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Abstract
Systemic lupus erythematosus is an immune-mediated syndrome in which the immune response is to noneorgan-specific antigens, and
virtually every organ in the abdominal cavity may become involved. Only renal involvement forms part of the diagnostic criteria, however,
a combination of typically nonspecific findings, including peritoneal surface, enteric, renal, renal tract, pancreatic, adrenal, hepatobiliary, and
splenic manifestations, should be looked for in patients with known lupus or other connective tissue disease who are undergoing abdominal
imaging and may suggest the diagnosis in patients presenting with an acute abdomen. Our work presents the spectrum of imaging findings of
abdominal manifestations of systemic lupus erythematosus.
Abre´ge´
Le lupus e´rythe´mateux disse´mine´ est une maladie auto-immune pre´sentant une re´ponse immunitaire non propre a` un organe. En effet, tous
les organes de la cavite´ abdominale peuvent eˆtre touche´s. Si l’atteinte re´nale constitue un des crite`res de diagnostic, une combinaison de
re´sultats habituellement aspe´cifiques, comme les manifestations pe´ritone´ales, ente´riques, re´nales, du tractus re´nal, pancre´atiques, surre´na-
liennes, he´patobiliaires et sple´niques, doit eˆtre recherche´e chez les patients souffrant de lupus ou d’une autre maladie du tissu conjonctif qui
doivent passer un examen d’imagerie abdominale. Ces signes peuvent e´galement sugge´rer un diagnostic chez les patients avec un abdomen
aigu. Nous pre´sentons le spectre complet des re´sultats d’imagerie des manifestations abdominales du lupus e´rythe´mateux disse´mine´.
 2009 Canadian Association of Radiologists. All rights reserved.
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www.carjonline.orgSystemic lupus erythematosus (SLE) is a diseaseofunknown
etiology in which tissues and cells are damaged by pathogenic
auto-antibodies and immune complexes. Up to 90% of affected
patients are female. The clinical course is characterized by
remissions and exacerbations, with mucocutaneous, cardiore-
spiratory, renal, and neurologic manifestations. Despite estab-
lished diagnostic criteria (Table 1) [1], many patients with SLE
also demonstrate features of other connective tissue diseases,
such as dermatomyositis or systemic sclerosis.
Abdominal manifestations may result from primary
involvement with SLE or from complications of therapy and
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doi:10.1016/j.carj.2009.06.001are well documented in the rheumatology literature [2e5].
Serositis and intestinal vasculitis can present with severe
abdominal pain and may masquerade as an acute surgical
abdomen. Small and large bowel ischemia may result from
vasculitis or vascular occlusion associated with the anti-
phospholipid syndrome. Renal involvement is common and
forms part of the diagnostic criteria (Table 1). The liver,
spleen, pancreas, adrenals, and genitourinary tract may also
become involved [2e4].
While the imaging appearances are typically nonspecific,
retrospective reviews suggest a diagnostic role for computed
tomography (CT) in patients with lupus enteritis [6e8].
Peritoneal surface, renal, renal tract, adrenal, hepatobiliary,
pancreatic, and splenic manifestations should be looked for
in patients with known lupus or other connective tissue
disease undergoing abdominal imaging and may suggest the
diagnosis in a patient presenting with an acute abdomen.All rights reserved.
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The 1982 Revised Criteria for Classification of Systemic Lupus Erythematosus*
Criterion Definition
1. Malar rash Fixed erythema, flat or raised, over the malar eminences, tending to spare the nasolabial folds
2. Discoid rash Erythematous raised patches with adherent keratotic scaling and follicular plugging; atrophic scarring
may occur in older lesions
3. Photosensitivity Skin rash as a result of unusual reaction to sunlight, by patient history or physician observation
4. Oral ulcers Oral or nasopharyngeal ulceration, usually painless, observed by physician
5. Arthritis Nonerosive arthritis involving 2 or more peripheral joints, characterized by tenderness, swelling, or effusion
6. Serositis a) Pleuritis: convincing history of pleuritic pain rubbing heard by a physician or evidence of
pleural effusion.
or
b) Pericarditis: documented by electrocardiogram or rub or evidence of pericardial effusion
7. Renal disorder a) Persistent proteinuria greater than 0.5 g/d or more than 3 þ if quantitation not performed
or
b) Cellular casts: may be red cell, hemoglobin, granular, tubular, or mixed
8. Neurologic disorder a) Seizures: in the absence of offending drugs or known metabolic derangements; eg, uremia,
ketoacidosis, or electrolyte imbalance
or
b) Psychosis: having excluded other causes, eg, drugs
9. Hematologic disorder a) Hemolytic anemia, with reticulocytosis
or
b) Leukopenia : <4.0  109/L on 2 or more occasions
or
c) Lymphopenia <1.5  109/L on 2 or more occasions
or
d) Thrombocytopenia: <100  109/L
10. Immunologic disorder a) Positive LE cell preparation
or
b) Anti-DNA: antibody to native DNA in abnormal titer
or
c) Anti-Sm: presence of antibody to Sm nuclear antigen
or
d) False-positive serologic test for syphilis known to be positive for at least 6 mo and confirmed by
Treponema pallidum immobilization or fluorescent treponemal antibody absorption test
11. Antinuclear antibody An abnormal titer of antinuclear antibody by immunofluorescence or an equivalent assay at any point in
time and in the absence of drugs known to be associated with ‘‘drug-induced lupus’’ syndrome
*From Ref. 1.Our work reviews the spectrum of imaging findings of
abdominal manifestations of SLE.
Serositis
Ascites occurs in approximately 10% of patients with
SLE (Figure 1). Possible causes include serositis, pancrea-
titis, nephritis and nephrotic syndrome, constrictive pericar-
ditis, and peritoneal inflammation secondary to vasculitis.
Chylous ascites is particularly unusual (Figure 2) [9]. Ascites
is an infrequent finding in patients with lupus nephritis and,
when present, is more likely to be due to peritoneal serositis
than hypoalbuminemia.
Serositis can develop when SLE is inactive but may also
manifest as peritonitis that may mimic an acute surgical
abdomen and lead to exploratory laparotomy. Low et al [10]
reported the characteristics of lupus serositis on barium small
bowel series as showing segments of spiculation with teth-
ering, angulation, and obstruction. CT demonstrated ascites
and asymmetric thickening of the small bowel wall. Lapa-
rotomy showed extensive patchy serosal and peritoneal
plaques, but biopsies did not reveal any specific lesions [10].Similar to vasculitis, ascites and serositis typically resolve
with high-dose steroid therapy [8].
Enteric Manifestations
Gastrointestinal (GI) involvement in SLE may be easily
overlooked since many GI symptoms can be attributed to
complications of drug therapy, such as nonsteroidal anti-
inflammatory drugs, steroids, and azathioprine. Involvement
of the GI tract in SLE is almost always accompanied by
evidence of active disease in other organs, although occa-
sionally it may be the main clinical feature [2].
Mouth ulcers may occur in up to 50% of patients with
SLE [3]. Mucosal ulcers usually occur in the hard palate,
buccal mucosa, or the vermilion border, and may be
erythematous and painless, or discoid and painful, causing
dysphagia or odynophagia [4].
Dysphagia may be secondary to a lack of saliva for
mastication as seen in Sjo¨gren syndrome, infection, or
esophageal dysmotility. Tertiary contractions, impaired
esophageal emptying and/or esophageal dilatation may be
seen on barium upper-GI series, and manometry may
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lower esophageal sphincter pressure, leading to reflux,
although severe involvement of the lower esophageal
sphincter is much more common in those patients with
clinical and serologic overlap with systemic sclerosis [3].
Such patients may demonstrate esophageal dilatation (Figure
1). Systemic vasculitis that involves the esophagus and
stomach may result in ulceration and perforation.
‘‘Watermelon stomach,’’ or gastric antral vascular ectasia,
has a well-recognized association with autoimmune disor-
ders and has been reported in association with SLE. Peptic
ulceration with perforation was reported by Medina et al [11]
in 5.8% (3/55) patients with SLE who presented with an
acute abdomen. The role of nonsteroidal anti-inflammatory
agents in causing these perforating ulcers was unclear.
Protein-losing enteropathy is an unusual presentation.
Hizawa et al [12] described the double-contrast radiographic
features in 6 patients with lupus-associated enteropathy. Two
Figure 2. Chylous ascites (asterisk), with fat/fluid level (arrow).
Figure 1. Axial computed tomography shows a dilated esophagus (asterisk),
pericardial and pleural effusion (arrows), and left basal consolidation.patients had protein-losing enteropathy with hyperlipidemia,
characterized by mildly thickened folds with multiple
submucosal nodules in the upper portion of the jejunum. In
one patient from this group, jejunal biopsy demonstrated
lymphangiectasia. Four patients had acute-onset enteritis
with irregular thickening and spiculation in the folds of
multiple segments from the duodenum to the terminal ileum,
accompanied by thumbprinting, suggestive of ischemic
change [12]. The association of SLE with inflammatory
bowel disease is unusual. A rare case of colonic carcinoma in
a patient with lupus and with collagenous colitis has been
reported [13].
Chronic intestinal pseudo-obstruction is an uncommon
complication of SLE, characterized by ineffective intestinal
propulsion. It may reflect a dysfunction of visceral smooth
muscle or the enteric nervous system [14]. In a series of 5
patients, Perlemuter et al [14] described imaging findings
of dilated, fluid-filled bowel loops and bilateral ureteral
dilatation, with a reduced urinary bladder capacity. In one
patient, histology showed normal innervation of the bowel
wall but with a marked fibrotic process in the muscularis
layer. Gastric scintigraphy showed delayed emptying. There
was manometric evidence of small bowel hypomotility with
reduced amplitude of contractions during phase III and
infrequent contractions during phase II of the migrating
motor complex [14]. Similar findings of dysmotility have
also been reported in patients who have overlap features
with scleroderma (Figure 3) and related disorders.
Vasculitis
Vasculitis in SLE may involve any part of the GI tract
from the esophagus to the rectum, although there is
a tendency for the vasculitis to affect the distribution of the
superior mesenteric artery [15]. Other causes of vascular
insufficiency should be considered before a diagnosis of
lupus vasculitis is made. For example, immunotherapy may
be associated with cytomegalovirus (CMV) and other
infections, leading to colitis. Thrombosis of mesenteric
vessels associated with the antiphospholipid syndrome (up to
a third of patients with SLE have antiphospholipid anti-
bodies) can give rise to visceral or mesenteric ischemia and
bowel infarction (Figures 4 and 5) [16].
The exact incidence of lupus vasculitis in the GI tract is
unknown. Literature review indicates that clinically apparent
bowel vasculitis occurs in fewer than 5% of patients with
SLE. Ramos-Casals et al [17] reviewed the prevalence of
vasculitis in 670 patients with SLE. Small arteries and
venules of the skin were the most common vessels involved,
typically associated with increased disease activity scores.
Medium vessel vasculitis was diagnosed on histology in one
patient with pancreatic involvement and in one patient with
gallbladder involvement. No bowel involvement was repor-
ted, and no details of imaging investigations were provided
[17]. Drenkard et al [18] reported only one case of mesenteric
vasculitis in 540 patients with SLE.
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articles suggest, as involvement may range from clinically
quiescent to mild colitis with diarrhoea, to mucosal ulcera-
tion with hemorrhage, to intestinal infarction and perfora-
tion. Although less common than involvement in the small
bowel, necrotizing vasculitis and perforating ulceration of
the appendix, transverse colon, splenic flexure, sigmoid
colon, and rectum in patients with SLE have been docu-
mented [19e21]. Vasculitis that involves intra-abdominal
vessels can result in aneurysmal dilatation and hemorrhage
from visceral arteries. The abdominal aorta may rarely be
affected.
There are several scoring systems for assessment of
disease activity in lupus that measure laboratory indices and
variably include organ weighting, antiedouble-stranded
DNA, complement, and assessment of fatigue [22]. The SLE
disease activity index (SLEDAI) is most commonly used, but
Figure 3. (A, B) A 38-year-old women with systemic lupus erythematosus
awaiting renal transplant. Clinically she also had overlapping features with
scleroderma, including severe dysmotility. Computed tomography demon-
strated a megaduodenum (asterisk) and small kidneys (arrows in A).
Enlarged, centrally hypoattenuating retroperitoneal lymph nodes (arrows in
B) were of unknown etiology. These resolved on follow-up imaging; biopsy
was not performed. There was no history of tuberculous disease.there are discordant reports regarding its usefulness as
a predictor of underlying enteritis in patients with acute
abdominal pain [23,24].
Figure 4. (A, B) A 39-year-old woman. Selected images from double-
contrast upper and lower gastrointestinal series demonstrate a blind ending
duodenum (black arrow in A) and transverse colon after massive small
bowel infarction. A gastrostomy is noted (large white arrow in A). There is
avascular necrosis of the left femoral head secondary to long-term cortico-
steroid use (asterisk).
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Vasculitis that affects the bowel typically appears as
circumferential, symmetric multisegmented bowel wall
thickening (Figures 6e8), primarily of the jejunum and ileum,
of variable length. It typically involves more than one vascular
territory [8,25]. CT findings in patients with lupus mesenteric
vasculitis that causes ischemic bowel include engorgement of
mesenteric vessels with a palisade pattern or comb-like
appearance; focal or diffusely dilated bowel loops (>3 cm);
ascites with increased peritoneal enhancement; thickening of
the small bowel, with a target sign; and increased attenuation
of mesenteric fat (Figure 7) [7,8]. Kim et al [26] suggested that
bowel wall thickness9 mm should be considered a high-risk
factor for recurrent enteritis.
Si-Hoe et al [6] reported nonspecific small bowel thick-
ening in 55% (30/54) and nonspecific colonic wall thick-
ening in 9% of patients with SLE (5/54) who underwent
abdominal CT for a variety of GI complaints. Clear evidence
Figure 5. Coronal portal phase computed tomography, demonstrating acute
superior mesenteric vein (SMV) thrombosis (arrow). The splenic vein is
patent (asterisk). Note the calcification in the splenic, portal, and superior
mesenteric veins from previous episodes of thrombosis. There is also
nonspecific colonic wall thickening in this patient.of ischemic bowel disease as described by Byun et al [7] was
seen in only 2 patients [6].
Kwok et al [23] diagnosed lupus enteritis in 47% of
patients with lupus (41/87) admitted to the hospital with
acute abdominal pain (excluding renal colic) over a 16-year
period. Clinical relapse occurred in 31% of patients after
a mean of 24 months. In 77% of clinical episodes, bowel wall
involvement was multisegmental and not confined to a single
vascular distribution. Autoantibody, including anti-
phospholipid, profiles were similar between patients with
enteritis and other causes of abdominal pain. Elevated
SLEDAI scores were consistent with active disease stage,
and most patients responded well to high-dose steroids [23].
Lian et al [27] retrospectively reviewed 52 patients with
SLE admitted with acute abdominal symptoms. Abdominal
pain (87%), vomiting (82%), and diarrhoea (67%) had been
present for a mean of 4.4 days, and the SLEDAI score was
elevated in 83% of patients. CT showed evidence of serositis
Figure 6. Ultrasound of colon in a patient with lupus who presented with
acute abdominal pain, demonstrating wall thickening, loss of normal gut
wall layers, consistent with colitis.
Figure 7. Computed tomography, demonstrating acute small bowel vascu-
litis. There is bowel wall thickening with target sign (arrows), dilatation of
intestinal segments, ascites, and stranding of mesenteric fat, consistent with
ischemic bowel disease.
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(lupus anticoagulant and anticardiolipin antibody positive) from age 20
years, presenting with acute periumbilical pain. On maintenance predniso-
lone. Off methotrexate for 6 mo. Computed tomography (CT), demon-
strating small bowel thickening and distension of jejunal loops (arrows in A),
consistent with vasculitis. This was treated with high-dose pulsed methyl-
prednisolone and resolved. Two years later, she re-presented with abdominal
pain and rectal bleeding. Catheter angiography was unremarkable. CT
demonstrated marked mucosal thickening over a long segment of transverseand bowel involvement in 63% of patients who underwent
this investigation. Parenteral steroids were used in 90% and
intravenous cyclophosphamide in 31% of patients. Most
patients (98%) were discharged in good condition. Recur-
rence of GI symptoms occurred in 23% of the patients [27].
Buck et al [28] retrospectively compared 56 patients with
SLE admitted with predominantly subacute abdominal pain
(without peritoneal signs) with 56 age- and sex-matched
‘‘controls’’ (patients without SLE admitted with abdominal
pain). Intestinal vasculitis was diagnosed in 5.4% of patients
with SLE compared with 0% of control patients (P < .05).
Only patients with SLEDAI scores >8 developed vasculitis
(P < .001), and the authors recommend restricting the use of
CT to diagnose vasculitis in patients with subacute abdominal
pain to those with SLEDAI scores >8 [28]. In contrast, al-
Hakeem and McMillen [29] recommended routine use of CT
in all patients with lupus and abdominal pain on steroids to
exclude perforated viscus. Buck et al [28] recommended the
routine use of CT to diagnose vasculitis in patients with
subacute abdominal pain only when SLEDAI scores were>8.
Medina et al [11] correlated SLEDAI scores and the cause
of acute abdomen in 51 patients with SLE. Patients with
intra-abdominal vasculitis (19 patients) or thrombosis (3
patients) had higher SLEDAI scores than patients with active
SLE and non-SLE related acute abdomen (14 patients) (mean
scores 17.5 vs 8.2). Fifteen patients with inactive SLE
(SLEDAI 1.7) had intra-abdominal pathology that was
diverse and not related to lupus. The investigators emphasize
early laparotomy in patients with active SLE with high
SLEDAI scores and an acute abdomen because the mortality
in this subgroup was very high [11].
In contrast, a retrospective study by Lee et al [24] found
no difference in age, sex, antibody profile, ESR, C-reactive
protein, or SLEDAI between patients with lupus enteritis,
diagnosed by clinical investigation and abdominal CT find-
ings (n ¼ 17) and those with other causes of abdominal pain
(n ¼ 21), although patients with enteritis were more likely to
be neutropenic [24].
Intramural gas (pneumatosis intestinalis) is uncommon
but may be seen in association with severe ischemia and with
necrotizing enterocolitis [3]. Although the outcome of
intestinal perforation secondary to lupus vasculitis is
extremely poor, generally the imaging appearance in lupus
enteritis is worse than the symptoms, and CT findings typi-
cally reverse after prompt administration of high-dose
steroids [7,8,24,25].
Urinary Tract
Proteinuria is the most common renal manifestation and
usually presents within the first 5 years after diagnosis.
colon (asterisk in B). Biopsy specimens were nonspecific but consistent with
ischemia (acute inflammatory exudate [inset] with oedema and hemorrhage
in lamina propria, focal tubule loss, and mucin loss in residual tubules;
negative for dysplasia). There was immediate symptomatic improvement
with high-dose steroids.
127J. M. Kirby et al. / Canadian Association of Radiologists Journal 60 (2009) 121e132Figure 9. (AeI) Various manifestations of lupus kidney: echogenic normal size (A); echogenic with focal hematoma (asterisk) after biopsy (B); enlarged, note
Simon Nitinol (IVC) filter (arrow) (C); focal infarcts (D, E, note congested liver); enlarged (F); small with cortical thinning. This patient also had chronic IVC
occlusion, with collateral veins over the anterior abdomen (G); small with nephrocalcinosis (arrows) (H), small, end stage (I).Microscopic hematuria is also almost always present, whereas
macroscopic hematuria is rare. Clinical lupus nephritis is one
of the major causes of morbidity and mortality in patients with
SLE and is observed in up to 60% of patients [30].
Virtually all patients with SLE have histologic abnor-
malities, including electron microscopic and/or immunoflu-
orescence evidence of immune complex deposits in the
glomeruli; however, the overriding characteristic of lupus
nephritis is its variability among patients, within biopsy
specimens, and even within glomeruli [30].
Imaging signs of renal involvement are nonspecific
(Figure 9). The kidneys may be normal, increased, or
decreased in size. Renal cortical echogenicity may range
from normal to echogenic. Cortical nephrocalcinosis may beseen in end-stage disease (arrows, Figure 9H). Other
nonspecific features that should be considered include focal
hematoma post biopsy, focal infarction, and scarring.
Patients with SLE are at increased risk for renal vein
thrombosis, particularly in patients in whom there is overlap
with antiphospholipid antibody/syndrome (Figure 10). Renal
vein thrombosis should be excluded if a patient with SLE and
with previously stable renal function develops rapidly
increasing proteinuria, nephrotic syndrome, pedal oedema,
or presents with deteriorating renal function [6]. Of the 65
CTs reviewed by Si-Hoe et al [6], 52 were undertaken to rule
out suspected renal vein or vena caval thrombosis; 13% of
patients had renal vein thrombosis, 71% of whom also had
thrombus in the IVC [6].
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hematuria and proteinuria or a fall in creatinine clearance.
Histologic glomerular and tubulointerstitial features may be
used to distinguish potentially reversible from chronic
disease. Biopsy also excludes nonlupus kidney disease, such
as renal thrombotic microangiopathy, drug-induced intersti-
tial nephritis, focal segmental glomerulosclerosis, and IgA
nephropathy, that may affect persons of similar age and sex.
The World Health Organization classification, originally
designated in 1982 and more recently evolved under the
auspices of both the International Society of Nephrology and
the Renal Pathology Society, has proven useful in prognos-
tication as a guide to therapy [31].
Urologic manifestations of SLE are uncommon and are
typically associated with GI disorders such as diarrhoea,
vomiting, malabsorption, ascites, and protein-losing enter-
opathy. Vasculitis-related lupus cystitis may cause a con-
tracted bladder, with diffuse wall thickening and resultant
hydronephrosis. Reduced bladder capacity may be secondary
to detrusor muscle spasm caused by bladder inflammation,
and immune complex deposition has been implicated.
Diffuse bladder wall thickening was diagnosed in 15% (5/32)
and bilateral hydronephrosis and hydroureter in 9% (3/32) of
patients with SLE who presented with abdominal symptoms
in a retrospective review of CT findings by Phongkitkarun
et al [25].
Min et al [32] diagnosed lupus cystitis in 5 of 413 patients
with SLE (1.2%). Bilateral hydroureteronephrosis and
thickened bladder wall were identified on abdominal ultra-
sound or CT. All patients with lupus cystitis showed GI
manifestations, such as abdominal pain, nausea, vomiting,
and/or diarrhoea, and abdominal CT revealed bowel wall
thickening in 4 of the 5 patients [32].
Chronic idiopathic intestinal pseudo-obstruction is known
to be associated with urologic manifestations, and this
association between cystitis and gut involvement in SLE may
Figure 10. A 47-year-old woman with acute pancreatitis complicated by
gastroduodenal artery (GDA) aneurysm. Portal venous phase computed
tomography, demonstrating resolving pseudocyst (arrow) and left renal vein
thrombosis (asterisk).
represent a distinct subgroup with a guarded prognosis,
despite aggressive immunosuppression, although in many
cases corticosteroids may reverse the inflammatory cystitis,
normalize bladder capacity and ureteric distension, and
improve bowel motility [14].
Pancreas
Pancreatitis (Figures 11 and 12) is an uncommon initial
presentation of SLE and occurs in approximately 5% of
patients with SLE, often secondary to vasculitis [33].
Necropsy findings of severe intimal proliferation have been
reported [33].
In contrast to lupus enteritis, lupus pancreatitis, even in
patients on steroid therapy, is usually symptomatic and
almost always presents acutely, typically with a flare-up that
involved multiple organs, although chronic pancreatitis has
been reported.
Nesher et al [34] reviewed 77 patients (88% women,
median age 27 years) with lupus pancreatitis. In 44% of
patients, pancreatitis developed within 1 year of the diag-
nosis of lupus, and 84% had active lupus at the time of
pancreatitis. Patients presented with abdominal pain (88%),
followed by nausea and/or vomiting (67%). Pancreatitis was
diagnosed on laboratory evidence of elevated serum amylase
or lipase in 97% of patients. Abdominal CT and ultraso-
nography did not show signs of pancreatic involvement in
24% and 45%, respectively. The mortality rate was 27%.
Active lupus and some biochemical abnormalities were
significantly associated with increased mortality. Patients
treated with corticosteroids or azathioprine after the onset of
pancreatitis had a 20% mortality compared with 61% among
those not treated (P ¼ .005) [34].
The pathogenesis of pancreatitis in patients with SLE is
controversial. Saab et al [35] found no role for steroids in the
pathogenesis of pancreatitis in SLE. Pascual-Ramos et al
[36], over a 7-year period, reviewed 49 episodes of acute
Figure 11. Portal venous phase computed tomography in a patient with lupus
and acute pancreatitis. There is extensive inflammatory change with a poorly
perfused pancreas (asterisk).
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estimated at 3.5%. Identified AP causes were mechanical in
28% and toxic metabolic, including steroids, in 20%. Idio-
pathic AP was more frequent in SLE cases (46%) than in
Figure 12. (AeC) A 24-year-old woman. Acute hemorrhagic pancreatitis;
hepatosplenic infarction (asterisk in A, B), and large retroperitoneal hema-
toma with fluid level (arrow in C). Laparotomy was negative for bleeding
source. Angiography (not shown) demonstrated very small vessels displaced
by collections and ascites, but no active bleeding source was identified. A
repeated angiogram 24 h later suggested a vascular blush that involved
pancreatic vessels arising from the splenic artery. The gastroduodenal artery
(GDA) and pancreatic branches were coiled. This patient died from multi-
organ failure.non-SLE ‘‘controls’’ (14%). The strength of association of
AP severity and related mortality was higher in patients with
SLE than in non-SLE controls (odds ratio 8.6 and 7.5,
respectively) [36].
Adrenal
Adrenal hemorrhage (Figure 13) and hypoadrenalism
(Figure 14) are well-recognized manifestations of both SLE
and primary antiphospholipid syndrome, and should be
excluded in such patients who complain of abdominal pain
and undue weakness or asthenia. Similarly, screening for
lupus anticoagulant and anticardiolipin antibodies has
been recommended in all cases of adrenal hemorrhage or
infarction [37].
Liver
Active liver disease is rare in SLE. Abnormal liver
function tests occur in up to 50% of patients, usually
secondary to medication, such as nonsteroidal anti-inflam-
matory drugs or azathioprine [38]. Antiphospholipid anti-
bodies in SLE may be associated with the Budd-Chiari
syndrome and present with abdominal pain, ascites, or
hepatic failure because of thrombosis of the portal vein and
hepatic veins (Figure 15).
Hepatomegaly, steatosis, chronic active hepatitis, granu-
lomatous hepatitis, cholestasis, centrilobular necrosis,
microabscesses, cirrhosis, including primary biliary cirrhosis
and hemochromatosis, have all been reported in association
with SLE.
Hepatitis in patients with SLE is associated with autoan-
tibodies such as anti-dS DNA and antiribosomal P, and is
most likely to be lobular. In contrast, autoimmune hepatitis is
more likely to be periportal (chronic active hepatitis), with
rosetting of liver cells and dense lymphoid infiltrates; it often
has specific autoantibodies to antieliver-specific protein or
Figure 13. Axial computed tomography, demonstrating bilateral acute
adrenal hemorrhage with fluid levels (arrows) in an anticoagulated patient
with lupus, presenting with acute abdominal pain.
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are associated with features of autoimmunity, such as poly-
arthralgia, hypergammaglobulinemia, and a positive antinu-
clear antibody (ANA). Autoimmune hepatitis is more
prevalent in patients with juvenile lupus. Necrotizing
vasculitis can affect the gall bladder and the bile ducts, and
may present as acalculous cholecystitis or benign biliary
stricture [39].
Spleen
Hyposplenism is infrequently described in patients with
SLE (up to 5% of patients) and is thought to be caused by
vasculitic changes within the spleen. A diagnosis of hypo-
splenism can easily be made by identifying Howell-Jolly
bodies on a peripheral blood smear. Multiple small asymp-
tomatic calcifications of the spleen have been reported in
isolated cases and may be directly related to the connective
tissue disease (Figure 16) [40,41]; however, there is a myriad
of potential causes for multiple splenic calcifications, for
example, granulomatous disease, particularly in areas
endemic for histoplasmosis, and correlation with clinical
history is required. In SLE, the small penicillar arteries of
splenic pulp typically develop concentric perivascular lami-
nations of fibrous tissue to produce the typical ‘‘onion skin’’
lesion, which is characteristic of, but no longer regarded as
specific for, SLE. Splenic infarction (Figure 12B, asterisk) is
not uncommon.
Pediatric Patients
The GI manifestations in childhood-onset SLE are outside
the scope of this article. Interested readers are referred to the
recent review on this subject by Richer et al [5].
Figure 14. Axial computed tomography, demonstrating nonvisualization of
the adrenal glands in a patient with lupus and with a remote history of
adrenal hemorrhage that resulted in adrenal insufficiency.Infective Complications
The nonspecific appearances of intra-abdominal infection
should not be overlooked in imaging the abdomen in patients
with SLE. Not only does the disease itself affect the immune
Figure 15. (AeC) A 22-year-old woman with lupus, right upper quadrant pain,
and mildly abnormal liver function tests. Axial T1 fat saturated post gadolinium
magnetic resonance imaging (A) and colour Doppler ultrasonography (B)
demonstrated the absence of flow in the right hepatic vein. Hepatic venography
confirmedawebat the right hepaticvenous exit (arrow inC).Transjugular biopsy,
was followed by angioplasty of the web with symptomatic improvement.
131J. M. Kirby et al. / Canadian Association of Radiologists Journal 60 (2009) 121e132system, but, in addition, many of the drugs used to treat SLE
also alter immune status, and opportunistic infections are,
therefore, more common. Heiberg et al [42] reported that mild
lymphadenopathy was the most frequent finding in a review of
55 CTs in 27 patients with SLE who were undergoing CT for
a variety of indications, particularly for suspected intra-
abdominal sepsis. Enlarged, centrally hypoattenuating retro-
peritoneal lymph nodes (Figure 3B) have been previously
described in SLE without associated infection [43], however,
infection, particularly mycobacterial, should form part of the
differential diagnosis.
Conclusion
SLE can involve any organ or region of the abdomen. The
authors recommend an organ- and/or systems-based
Figure 16. (A, B)Multiple focal splenic calcifications in 2 patients with lupus,
in a normal size spleen on ultrasound (A) and in a shrunken spleen on axial
CT in (B). Neither patient had a history of tuberculosis or histoplasmosis.approach to imaging. Although abdominal symptoms in
lupus are most likely to be due to of the same conditions
as those found in patients without lupus, a spectrum of
abdominal imaging findings, including involvement of the
peritoneal surfaces, GI tract, kidney, pancreas, adrenals,
liver, and spleen, along with systemic vascular involvement,
should be looked for in patients with known lupus or other
connective tissue disease undergoing abdominal imaging and
may suggest the diagnosis in a patient presenting with an
acute abdomen.
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